Which cells of the immune system are directly activated by Erbisol?

Erbisol directly activates the macrophage link of the immune system. During immunomodulation, the drug also stimulates the synthesis of cytokines such as interferon, interleukin-2, and tumor necrosis factor.

What is the leading pharmacological activity of Erbisol?

The primary and leading direction of the drug's pharmacological action is its immunomodulatory activity.

Which compounds does the drug stimulate the synthesis of?

The drug stimulates the production of crucial cytokines such as interferons (IFN), interleukin-2 (IL-2), and tumor necrosis factor (TNF).

Is Erbisol used as a monotherapy?

According to medical indications, the drug is used as part of combination therapy for various diseases.

Home › Pharmacology › Erbisol: Pharmacology, Mechanism and Clinical Use

Erbisol

Erbisolum

For medical students2 min readUpdated 2026-10-10

Erbisol is a unique complex of low-molecular-weight peptides with a pronounced spectrum of pharmacological activity. The drug is widely used in combination therapy for various pathological conditions due to its potent immunomodulatory and protective effects on the body.

Drug compositionComplex of low-molecular-weight peptides

Primary actionImmunomodulatory activity

Clinical roleUse in combination therapy

Pharmacological Profile and Activity

The pharmacological properties of the drug are complex in nature. The primary direction of its action is immunomodulatory activity.

In addition, the pharmacological spectrum includes:

anti-inflammatory effects;
antioxidant protection;
membrane-stabilizing function;
adaptogenic properties.

Mechanisms of Immunomodulatory Action

The therapeutic effect is based on influencing the body's defense mechanisms at the cellular and molecular levels. The mechanism of immunomodulation is implemented through two key directions:

Direct activation of the macrophage system.
Active stimulation of cytokine synthesis, including interferons, interleukin-2 (IL-2), and tumor necrosis factor (TNF).

Indications for Clinical Use

The drug is prescribed as part of complex treatment regimens for a wide range of nosologies. In clinical practice, it is used for:

diabetes mellitus;
erosive and ulcerative lesions of the gastrointestinal tract;
hepatitis of various etiologies;
various respiratory system diseases;
chronic fatigue syndrome;
oncological pathologies.

Mnemonic

Erbisol represents Immunity and Peptides (IP): the peptide complex stimulates interferons and macrophages while protecting cell membranes.

Frequently asked questions

Which cells of the immune system are directly activated by Erbisol?: Erbisol directly activates the macrophage link of the immune system. During immunomodulation, the drug also stimulates the synthesis of cytokines such as interferon, interleukin-2, and tumor necrosis factor.
What is the leading pharmacological activity of Erbisol?: The primary and leading direction of the drug's pharmacological action is its immunomodulatory activity.
Which compounds does the drug stimulate the synthesis of?: The drug stimulates the production of crucial cytokines such as interferons (IFN), interleukin-2 (IL-2), and tumor necrosis factor (TNF).
Is Erbisol used as a monotherapy?: According to medical indications, the drug is used as part of combination therapy for various diseases.

Go deeper

Detailed analysis of the role of macrophages in immunomodulation
The cascade of interleukin-2 and tumor necrosis factor synthesis induced by peptides
Features of membrane-stabilizing and antioxidant effects
Pathogenetic rationale for use in erosive and ulcerative GI lesions and hepatitis
Mechanisms of the drug's adaptogenic action in chronic fatigue syndrome